Immediate-release omeprazole + Delayed-release omeprazole

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
80
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Gastroparesis

Conditions

Gastroparesis, Gastroesophageal Reflux Disease

Trial Timeline

Jun 1, 2007 โ†’ Dec 1, 2008

About Immediate-release omeprazole + Delayed-release omeprazole

Immediate-release omeprazole + Delayed-release omeprazole is a approved stage product being developed by Bausch Health for Gastroparesis. The current trial status is completed. This product is registered under clinical trial identifier NCT00492622. Target conditions include Gastroparesis, Gastroesophageal Reflux Disease.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00492622ApprovedCompleted

Competing Products

19 competing products in Gastroparesis

See all competitors
ProductCompanyStageHype Score
tadalafil + tadalafil + placeboEli LillyPhase 2
52
GranisetronKyowa KirinPhase 2
52
tadalafilEli LillyApproved
85
Mosapride + domperidoneSumitomo PharmaApproved
85
Cisapride + PlaceboJohnson & JohnsonApproved
85
Cisapride + PlaceboJohnson & JohnsonApproved
85
Naloxegol 25 MG Oral Tablet [Movantik] + Placebo Oral TabletAstraZenecaPhase 2
52
Sitagliptin + PlaceboMerckPhase 1
33
TegaserodNovartisApproved
85
Reglan ODTUCBPre-clinical
20
Hemin + AlbuminRecordatiPhase 2
49
CNSA-001 + PlaceboPTC TherapeuticsPhase 2
49
Velusetrag + PlaceboTheravance BiopharmaPhase 2
47
velusetrag dose 1 + velusetrag dose 2 + velusetrag dose 3 + placeboTheravance BiopharmaPhase 2
47
IW-9179 + Matching PlaceboIronwood PharmaceuticalsPhase 2
44
VLY-686 (Tradipitant)Vanda PharmaceuticalsPhase 2
44
TradipitantVanda PharmaceuticalsPhase 3
69
TradipitantVanda PharmaceuticalsPre-clinical
15
Tradipitant + Placebo + Open Label TradipitantVanda PharmaceuticalsPhase 3
69